Click to search for your profile
Click to search for condition or expert
Click to open main menu
Hemorrhagic Proctocolitis Latest Advances
Find the latest research about Hemorrhagic Proctocolitis.
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Journal:
Microbiome
Published —
April 06, 2021
Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPARγ signaling activation.
Condition:
Ulcerative Colitis (UC)
Journal:
Journal of gastrointestinal and liver diseases : JGLD
Treatment Used:
Adalimumab (ADA)
Number of Patients:
22
Published —
March 16, 2021
This study assessed the use of adalimumab (ADA) in patients with ulcerative colitis in deep remission.
Condition:
Inflammatory Bowel Disease
Journal:
JAMA network open
Treatment Used:
Corticosteroids and Anti-Tumor Necrosis Factor (TNF) Drugs
Number of Patients:
2997
Published —
March 01, 2021
The study researched the use of corticosteroids and anti-tumor necrosis factor (TNF) drugs for treating inflammatory bowel disease in veterans.
Condition:
Refractory Pyoderma Gangrenosum (PG)
Journal:
BMJ case reports
Treatment Used:
Hyperbaric Oxygen Therapy
Number of Patients:
1
Published —
February 19, 2021
This article reviewed a patient with refractory (resistant to treatment) pyoderma gangrenosum (condition that causes large, painful sores to develop on the skin, most often on the legs; PG) treated with hyperbaric oxygen therapy (involves breathing almost pure oxygen in a special room or small chamber).
Condition:
Ulcerative Colitis
Journal:
PloS one
Treatment Used:
Cannabis
Number of Patients:
32
Published —
February 11, 2021
The study researched the outcomes of cannabis in patients with ulcerative colitis.
Condition:
Squamous Cell Carcinoma at the site of Ileo-Anal Pouch in Crohn's Disease
Journal:
BMJ case reports
Treatment Used:
Surgical Therapy and Chemoradiotherapy
Number of Patients:
1
Published —
February 09, 2021
This case report describes a patient with squamous cell carcinoma at the site of their ileo-anal pouch and Crohn's disease.
Condition:
Primary Sclerosing Cholangitis with Ulcerative Colitis
Journal:
The Tohoku journal of experimental medicine
Treatment Used:
Ursodeoxycholic Acid
Number of Patients:
1
Published —
February 08, 2021
This case report describes an 11-year-old girl diagnosed with ulcerative colitis who developed primary sclerosing cholangitis (bile duct inflammation) treated with ursodeoxycholic acid.
Condition:
Inflammatory Bowel Disease (IBD)
Journal:
BMC pediatrics
Treatment Used:
Biologic Therapy
Number of Patients:
100
Published —
February 05, 2021
This study evaluated the impact of biologic therapy (designed to stimulate or restore the ability of the body's immune system to fight infection and disease) in pediatric patients with inflammatory bowel disease (group of disorders in which the intestines become inflamed; IBD).
Condition:
Enterocutaneous Fistula
Journal:
Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica
Treatment Used:
Laser Diode and Cyanoacrylates
Number of Patients:
1
Published —
January 28, 2021
This article reviewed the case of a patient with enterocutaneous fistula (abnormal communication between the small or large bowel and the skin that allows the contents of the stomach or intestines to leak through an opening in the skin) managed with laser diode (semiconductor device that generates coherent light of high intensity) and cyanoacrylate (strong fast-acting adhesives) embolization.
Condition:
Ulcerative Colitis
Journal:
Middle East African journal of ophthalmology
Treatment Used:
Adalimumab
Number of Patients:
1
Published —
January 25, 2021
The study researched the outcomes of Adalimumab in patients with ulcerative colitis.
Condition:
Ulcerative Colitis and Crohn's Disease
Journal:
BMC gastroenterology
Treatment Used:
Vedolizumab
Number of Patients:
100
Published —
January 23, 2021
This study tested the safety and efficacy of using vedolizumab to treat patients with ulcerative colitis and Crohn's disease.
Condition:
Ulcerative Colitis
Journal:
The Permanente journal
Treatment Used:
Infliximab and a Plant-Based Diet
Number of Patients:
17
Published —
January 23, 2021
The study investigated the outcomes of infliximab and a plant-based diet (PBD) as first-line therapy for severe ulcerative colitis.
Showing 1-12 of 309
Next